PIB / audit GMP / AQC et de la formation

gcp sertifikat

 

NBScience limitée helps companies reduce the time it takes to put their products on the market by educating and assisting Assurance qualité personnel in implementing FDA/EMEA Compliant Quality Systems.

We specialize in assisting pharmaceutical, biotechnologie, biologics, dispositif médical, and their affiliated industries with auditing relative to Good Clinical Practices, GCP, Bonnes pratiques de distribution, PIB, Bonnes pratiques de laboratoire,GLP, and Good Manufacturing Practices, GMP.

Pour plus de détails s'il vous plaît nous contacter par e-mail: head_office@nbscience.com

1) CQA ( Certified Quality Auditor ) certification

Détails – AQC vérificateur de certification

2) GDP audit

How will it Work?

Supplier Initiated Process

•Excipient supplier selects NBScience GDP Auditor

•Supplier identifies if GDP parts are needed

•At least Annual surveillance audits and triennial re-certificationa frequency likely to be higher than any excipient user could manage, even for high risk excipients

 

NBScience Auditing Body Actions

•The GDP audit report lists observations and rates findings as life threatening, critical, major or minor

•Life threatening observations are a stop point

• NBScience required to instruct the excipient supplier immediately to notify all customers of the situation

•Certification Board review audit report and findings, recommend certification if

•No life threatening critical, no major without CAPA, no minors that indicate failure of quality system element

More than a Certificate….

•A GDP Certificate is issued to the excipient supplier along with an audit report

•The excipient supplier should make the Audit Reports and GDP Certificate available to the pharmaceutical excipient user(s)

•Entire information about level of GDP of the supplier with the pharmaceuticals company for evaluation

•The Audit Report may be redacted to show that confidential information has been hidden – but substance of report will not be altered

Time and Cost

•The overall NBScience GDP audit will last 4-6 man days typically

•The cost for the audit will be at day rate (typically 1500 Euro per day, per person) (environ. 3000-5000 Euro per location)

•On top NBScience to charge a GDP certification fee of 3000 Euros every 3 années

•Surveillance audits annually will last approx. 2 journées (environ. 4000-6000 Euros per year)

•The GDP certificate needs to be renewed every 3 années

 

For a more accurate calculation of the amount we need to get the full information about warehousing location, description and employees.

Exemple:

Pilot audit phase – Audit for GDP (février 2014)

•Company: X-pharma (Allemagne, manufacture and distribution)

•6 hectare on 2 des sites, 8 excipients, 165 employees on 2 des sites

•Manufacture: aqueous solution, packaging in clean-rooms, lab testing

•Distribution: warehousing, shipment/delivery, re-packaging

•4 auditor man days on one site, 1 auditor day at affiliate

•2 auditor man days preparation and 20 page report

•Audit of larger site witnessed by NBScience contracted experts

•Audit at certification body offices completed

PIB ( Bonnes pratiques de distribution ) Cours en ligne

 

congrès médicaux

3) Good manufacturing practice GMP audit

GMPis part of a quality system covering the manufacture and testing of pharmaceutical dosage forms or drugs and active pharmaceutical ingredients, diagnostics, foods, produits pharmaceutiques, and medical devices. GMPs are guidance that outline the aspects of production and testing that can impact the quality of a product. Many countries have legislated that pharmaceutical and medical device companies must follow GMP procedures, and have created their own GMP guidelines that correspond with their legislation, basic concepts of all these guidelines remains more or less similar that is ultimate goal to safeguard the health of the patient, producing a good quality medicine or medical devices or active pharmaceutical products.

Although there are a number of them, all guidelines follow a few basic principles.

  • Manufacturing processes are clearly defined and controlled. All critical processes are validated to ensure consistency and compliance with specifications.
  • Manufacturing processes are controlled, and any changes to the process are evaluated. Changes that have an impact on the quality of the drug are validated as necessary.
  • Instructions and procedures are written in clear and unambiguous language. (Good Documentation Practices)
  • Operators are trained to carry out and document procedures.
  • Records are made, manually or by instruments, during manufacture that demonstrate that all the steps required by the defined procedures and instructions were in fact taken and that the quantity and quality of the drug was as expected. Deviations are investigated and documented.
  • Records of manufacture (including distribution) that enable the complete history of a batch to be traced are retained in a comprehensible and accessible form.
  • The distribution of the drugs minimizes any risk to their quality.
  • A system is available for recalling any batch of drug from sale or supply.
  • Complaints about marketed drugs are examined, the causes of quality defects are investigated, and appropriate measures are taken with respect to the defective drugs and to prevent recurrence.

GMP guidelines are not prescriptive instructions on how to manufacture products. They are a series of general principles that must be observed during manufacturing. When a company is setting up its quality program and manufacturing process, there may be many ways it can fulfill GMP requirements. It is the company’s responsibility to determine the most effective and efficient quality process.

Pour plus de détails s'il vous plaît nous contacter par e-mail: head_office@nbscience.com

_________________________________________________________

formation GMP

 

congrès médicaux

Programme:

 Principes de base des BPF    
Introduction au cours de la formation
Gestion de la qualité
L'assainissement et l'hygiène
Qualification et validation
Plaintes et rappels
la production et l'analyse du contrat
Auto-inspection et audits de qualité
Personnel
Locaux
Équipement
Matériaux
Documentation
Les bonnes pratiques de production et de contrôle de la qualité
production stérile
Ingrédient pharmaceutique actif
 Processus d'inspection des BPF 
introduction [
The role of the inspector
Preparation for an inspection
Types of GMP inspection
The inspection

_______________________________________________

thérapie de cellules souches